PECAM1 and Alzheimer disease: Notably, CD31 fluorescence and Aβ fluorescence colocalization significantly increased in patients with AD (control mean = 0.30, AD mean = 0.35, Z = −2.01, p = 0.044) in Spearman’s correlation rank analysis (Figure 1D).